GPN vs NTLA · P/E 24, rev $6.29B vs rev $22.7M
Global Payments Inc (GPN) versus Intellia Therapeutics Inc (NTLA) — a side-by-side from cached financials, not a winner call.
Global Payments Inc (GPN) is a specialty business services company listed on US.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Latest reported GPN revenue for 2026-06-30 was $6.29B. Net income was -$1.79B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
Latest reported NTLA revenue for 2026-06-30 was $22.7M. Net income was -$202.9M. Revenue was up 50.9% from 2026-03-31 to 2026-06-30. NTLA currently screens at market cap $1.19B.
GPN currently screens at market cap $18.14B and trailing P/E 24.4. NTLA currently screens at market cap $1.19B.
Not investment advice. Open the GPN and NTLA stock pages for the full models.
Not investment advice.